The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes with COVID-19 in hematopoietic stem cell transplant and cellular therapy patients.
 
Muhammad Umair Mushtaq
No Relationships to Disclose
 
Mary Luder
No Relationships to Disclose
 
Moazzam Shahzad
No Relationships to Disclose
 
Nausheen Ahmed
No Relationships to Disclose
 
Haitham Abdelhakim
No Relationships to Disclose
 
Rajat Bansal
No Relationships to Disclose
 
Ramesh Balusu
No Relationships to Disclose
 
Sibgha Gull Chaudhary
No Relationships to Disclose
 
Shaun DeJarnette
No Relationships to Disclose
 
Clint Divine
No Relationships to Disclose
 
Robert Kribs
No Relationships to Disclose
 
Leyla Shune
No Relationships to Disclose
 
Anurag K Singh
No Relationships to Disclose
 
Sunil H. Abhyankar
Consulting or Advisory Role - Incyte
Speakers' Bureau - Therakos
Research Funding - Incyte
 
Siddhartha Ganguly
Honoraria - Astellas Pharma; Kite, a Gilead company; Seagen
Consulting or Advisory Role - Bristol-Myers Squibb; Daiichi Sankyo/Lilly; Sanofi/Aventis
Speakers' Bureau - Kite, a Gilead company; Seagen
Research Funding - Daiichi Sankyo (Inst); Janssen (Inst)
Travel, Accommodations, Expenses - Kite, a Gilead company; Seagen
 
Joseph McGuirk
Honoraria - AlloVir; Juno Therapeutics; Kite, a Gilead company; Magenta Therapeutics
Consulting or Advisory Role - Allovir; EcoR1 Capital; Juno Therapeutics; Kite, a Gilead company; Magenta Therapeutics
Speakers' Bureau - Kite/Gilead
Research Funding - AlloVir (Inst); Astellas Pharma (Inst); Bellicum Pharmaceuticals (Inst); Fresenius Biotech (Inst); Gamida Cell (Inst); Kite, a Gilead company (Inst); Novartis (Inst); Novartis (Inst); Pluristem Therapeutics (Inst)
Travel, Accommodations, Expenses - Kite, a Gilead company